View of Screening of cellular immunity of T cells in endometrial cancer patients via measurement of interferon gamma, interleukin 22, interleukin 17, interleukin 13, interleukin 10, interleukin 4, interleukin 2, and tumor necrosis factor alpha cytokines | Zanco Journal of Medical Sciences (ZJMS)

← Screening of cellular immunity of T cells in endometrial cancer patients via measurement of interferon gamma, interleukin 22, interleukin 17, interleukin 13, interleukin 10, interleukin 4, interleukin 2, and tumor necrosis factor alpha cytokines